Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis

PLoS One. 2015 Dec 11;10(12):e0143757. doi: 10.1371/journal.pone.0143757. eCollection 2015.

Abstract

Objectives: Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin- Like Receptors (KIR) on their surface. KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class І genes as their corresponding ligands in RA patients and control subjects.

Methods: In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). Differences in the frequency of genes and haplotypes were determined by χ² test.

Results: KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). Inhibitory haplotype No. 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA.

Conclusion: Individuals carrying the inhibitory KIR haplotype No. 6 have a high potential risk for developing RA.

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / genetics*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / pathology
  • Case-Control Studies
  • Disease Resistance / immunology*
  • Female
  • Gene Expression
  • Genetic Predisposition to Disease*
  • HLA-C Antigens / genetics*
  • HLA-C Antigens / immunology
  • Haplotypes
  • Humans
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / pathology
  • Male
  • Middle Aged
  • Molecular Typing
  • Pseudogenes
  • Receptors, KIR / genetics*
  • Receptors, KIR / immunology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology

Substances

  • HLA-C Antigens
  • Receptors, KIR

Grants and funding

The authors have no support or funding to report.